Exploring and Exploiting Genetic Risk for Psychiatric Disorders: Strungmann Forum Reports
Editat de Elisabeth Binder, Joshua A. Gordonen Limba Engleză Paperback – 10 oct 2023
Preț: 340.16 lei
Nou
Puncte Express: 510
Preț estimativ în valută:
65.11€ • 68.30$ • 54.01£
65.11€ • 68.30$ • 54.01£
Carte disponibilă
Livrare economică 08-22 ianuarie 25
Livrare express 24-28 decembrie pentru 35.18 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780262547383
ISBN-10: 0262547384
Pagini: 340
Ilustrații: 15 COLOR ILLUS., 4 B&W ILLUS., 3 HALFTONES
Dimensiuni: 229 x 152 x 22 mm
Greutate: 0.45 kg
Editura: MIT Press Ltd
Seria Strungmann Forum Reports
ISBN-10: 0262547384
Pagini: 340
Ilustrații: 15 COLOR ILLUS., 4 B&W ILLUS., 3 HALFTONES
Dimensiuni: 229 x 152 x 22 mm
Greutate: 0.45 kg
Editura: MIT Press Ltd
Seria Strungmann Forum Reports
Notă biografică
edited Joshua A. Gordon and Elisabeth B. Binder
Cuprins
List of Contributors vii
Preface xi
1 Exploring and Exploiting Genetic Risk for Psychiatric Disorders 1
Gene Discovery
2 Delineating Additional Risk Factors 13
3 Data Collection: Next Steps in Psychiatric Genetics 39
4 Environmental Risk and Gene-Environment Relationships in Psychiatric Disorders 51
Understanding Rare Variation
5 Rare Variants: Shared Paths for Therapeutic Development and Neurobiological Investigation 69
6 Promises and Challenges of Precision Medicine in Rare Neurodevelopmental Disorders 103
7 Experimental Model Systems for Rare and Common Variants 117
Understanding Common Variation
8 Common Alleles: Next Steps in the Study of Common Variants 131
9 Hypotheses of How Common Variants Create Risk for Psychiatric Disorders 155
10 From Common Variant to Function: State-of-the-Art Approaches 167
11 Contextualizing Convergent Common Variant Mechanisms through Systems Biology 179
Clinical Considerations
12 Maximizing Near-Term Clinical Opportunities for Psychiatric Genetics 201
13 The Use of Polygenic Risk Scores in Clinical Psychiatry: Opportunities and Obstacles 219
14 Ethical Challenges Associated with Advances in Genetic Prediction of Neuropsychiatric Disorders 237
15 Psychiatric Genetic Counseling: Next Steps 249
16 Concluding Summary 261
Bibliography 267
Subject Index 319
Strungmann Forum Report Series 325
Preface xi
1 Exploring and Exploiting Genetic Risk for Psychiatric Disorders 1
Gene Discovery
2 Delineating Additional Risk Factors 13
3 Data Collection: Next Steps in Psychiatric Genetics 39
4 Environmental Risk and Gene-Environment Relationships in Psychiatric Disorders 51
Understanding Rare Variation
5 Rare Variants: Shared Paths for Therapeutic Development and Neurobiological Investigation 69
6 Promises and Challenges of Precision Medicine in Rare Neurodevelopmental Disorders 103
7 Experimental Model Systems for Rare and Common Variants 117
Understanding Common Variation
8 Common Alleles: Next Steps in the Study of Common Variants 131
9 Hypotheses of How Common Variants Create Risk for Psychiatric Disorders 155
10 From Common Variant to Function: State-of-the-Art Approaches 167
11 Contextualizing Convergent Common Variant Mechanisms through Systems Biology 179
Clinical Considerations
12 Maximizing Near-Term Clinical Opportunities for Psychiatric Genetics 201
13 The Use of Polygenic Risk Scores in Clinical Psychiatry: Opportunities and Obstacles 219
14 Ethical Challenges Associated with Advances in Genetic Prediction of Neuropsychiatric Disorders 237
15 Psychiatric Genetic Counseling: Next Steps 249
16 Concluding Summary 261
Bibliography 267
Subject Index 319
Strungmann Forum Report Series 325